Date | Source | Headline | |
---|---|---|---|
24th Mar 2020 | 8:55 am | RNS | Form 8 (DD) |
23rd Mar 2020 | 1:19 pm | RNS | Holding(s) in Company |
23rd Mar 2020 | 12:37 pm | RNS | Form 8.5 - Redx Pharma Plc |
23rd Mar 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
23rd Mar 2020 | 10:42 am | RNS | Form 8 (DD) - Redx Pharma PLC |
20th Mar 2020 | 4:37 pm | RNS | Form 8.3 - Redx Pharma plc |
20th Mar 2020 | 4:30 pm | RNS | Form 8.3 - Redx Pharma |
20th Mar 2020 | 1:55 pm | RNS | Holding(s) in Company |
19th Mar 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
18th Mar 2020 | 2:01 pm | RNS | Form 8.3 - Redx Pharma PLC |
17th Mar 2020 | 2:54 pm | RNS | Form 8.3 - Seneca Partners Limited |
17th Mar 2020 | 2:30 pm | RNS | Form 8 (OPD) Redx Pharma plc |
17th Mar 2020 | 2:23 pm | GNW | Form 8.3 - AXA INVESTMENT MANAGERS: Redx Pharma PLC |
17th Mar 2020 | 2:14 pm | RNS | Form 8.3 - RedX Pharma plc |
17th Mar 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
16th Mar 2020 | 5:31 pm | RNS | Holding(s) in Company |
16th Mar 2020 | 5:30 pm | RNS | Holding(s) in Company |
16th Mar 2020 | 2:47 pm | RNS | Form 8.3 - Redx Pharma plc |
16th Mar 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
16th Mar 2020 | 9:53 am | RNS | Form 8.3 - [REDX PHARMA PLC] |
13th Mar 2020 | 7:37 am | RNS | Holdings in Company |
13th Mar 2020 | 7:12 am | RNS | RECOMMENDED MANDATORY OFFER FOR REDX PHARMA PLC |
13th Mar 2020 | 7:00 am | RNS | Confirmation of Private Approach |
11th Mar 2020 | 7:00 am | RNS | Final Results for Year Ended 30 September 2019 |
9th Mar 2020 | 10:05 am | RNS | Holding(s) in Company |
2nd Mar 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
2nd Mar 2020 | 7:00 am | RNS | Re-release: Funding Update |
28th Feb 2020 | 6:29 pm | RNS | Funding update |
28th Feb 2020 | 5:56 pm | RNS | Termination of discussions with Yesod Bio-Sciences |
28th Feb 2020 | 4:57 pm | RNS | Rule 2.8 Announcement |
27th Feb 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
26th Feb 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
25th Feb 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
24th Feb 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
20th Feb 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
19th Feb 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
18th Feb 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
17th Feb 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
14th Feb 2020 | 4:16 pm | RNS | Further statement re Rule 2.6 Extension |
14th Feb 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
13th Feb 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
12th Feb 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
11th Feb 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
10th Feb 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
7th Feb 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
4th Feb 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
3rd Feb 2020 | 6:27 pm | RNS | Form 8.3 - RedX Pharma PLC |
3rd Feb 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
30th Jan 2020 | 11:45 am | RNS | Form 8.5 (EPT/RI) |
28th Jan 2020 | 7:00 am | RNS | Statement re Rule 2.6 Extension |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.